Cancer News and Research

Latest Cancer News and Research

HEALTH-TECH project approved by European Commission to establish centre of excellence for healthy ageing

HEALTH-TECH project approved by European Commission to establish centre of excellence for healthy ageing

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

AWMSG recommends Daklinza (daclatasvir) for treatment of adult patients with chronic HCV infection

AWMSG recommends Daklinza (daclatasvir) for treatment of adult patients with chronic HCV infection

Researchers identify immune system marker that drives therapy-resistant prostate cancer

Researchers identify immune system marker that drives therapy-resistant prostate cancer

Medical experts call for accurate, standardized estrogen testing methods

Medical experts call for accurate, standardized estrogen testing methods

Eating less late at night may help reduce effects of sleep deprivation

Eating less late at night may help reduce effects of sleep deprivation

Finding could help researchers develop new methods to prevent cognitive decline in Alzheimer's disease

Finding could help researchers develop new methods to prevent cognitive decline in Alzheimer's disease

IDMC recommends continuation of Argos’ ADAPT phase 3 trial of AGS-003 in mRCC patients

IDMC recommends continuation of Argos’ ADAPT phase 3 trial of AGS-003 in mRCC patients

PQBP1 protein could improve body's immune response to HIV vaccines

PQBP1 protein could improve body's immune response to HIV vaccines

Research shows how social network analysis can help identify cancer biomarkers

Research shows how social network analysis can help identify cancer biomarkers

Seattle Children's opens enrollment for first clinical trial of Tumor Paint BLZ-100 for children with brain tumors

Seattle Children's opens enrollment for first clinical trial of Tumor Paint BLZ-100 for children with brain tumors

Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia

Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia

Montefiore's School Health Program awarded $3 million grant to support teen pregnancy prevention initiative

Montefiore's School Health Program awarded $3 million grant to support teen pregnancy prevention initiative

Houston Methodist Hospital and MD Anderson Cancer Center surgeons successfully perform multi-organ transplant

Houston Methodist Hospital and MD Anderson Cancer Center surgeons successfully perform multi-organ transplant

Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured breast implants

Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured breast implants

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

University of Chicago scientists develop new technique to accurately measure epigenetic changes

University of Chicago scientists develop new technique to accurately measure epigenetic changes

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Penn Medicine researchers explore primary player involved in T cell exhaustion

Penn Medicine researchers explore primary player involved in T cell exhaustion

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.